 Kathleen Simpson
Concepts (158)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Transplantation | 33 | 2025 | 675 | 5.220 |
Why?
| | Fontan Procedure | 12 | 2025 | 188 | 3.450 |
Why?
| | Heart-Assist Devices | 20 | 2025 | 568 | 2.800 |
Why?
| | Heart Defects, Congenital | 18 | 2025 | 904 | 2.360 |
Why?
| | Heart Failure | 20 | 2025 | 2324 | 1.530 |
Why?
| | Myocarditis | 5 | 2016 | 102 | 1.530 |
Why?
| | Registries | 12 | 2025 | 2401 | 0.910 |
Why?
| | Cardiomyopathy, Restrictive | 1 | 2025 | 11 | 0.900 |
Why?
| | Cardiomyopathy, Dilated | 3 | 2021 | 356 | 0.840 |
Why?
| | Cardiomyopathy, Hypertrophic | 1 | 2025 | 143 | 0.810 |
Why?
| | Child | 45 | 2025 | 22670 | 0.780 |
Why?
| | Lymphopenia | 1 | 2022 | 62 | 0.740 |
Why?
| | Postoperative Complications | 4 | 2024 | 2961 | 0.720 |
Why?
| | Enterovirus | 2 | 2015 | 83 | 0.710 |
Why?
| | Child, Preschool | 28 | 2025 | 11835 | 0.670 |
Why?
| | Kidney Diseases | 1 | 2022 | 424 | 0.560 |
Why?
| | Retrospective Studies | 28 | 2025 | 17247 | 0.550 |
Why?
| | Liver Diseases | 1 | 2021 | 304 | 0.540 |
Why?
| | Adolescent | 30 | 2025 | 22479 | 0.520 |
Why?
| | Graft Rejection | 5 | 2022 | 518 | 0.510 |
Why?
| | Ventricular Function, Right | 1 | 2019 | 296 | 0.510 |
Why?
| | Infant | 18 | 2025 | 10060 | 0.510 |
Why?
| | Parvovirus B19, Human | 1 | 2015 | 3 | 0.470 |
Why?
| | Cardiac Myosins | 1 | 2016 | 37 | 0.460 |
Why?
| | Herpesvirus 6, Human | 1 | 2015 | 14 | 0.460 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2016 | 125 | 0.440 |
Why?
| | Adenoviridae | 1 | 2015 | 199 | 0.430 |
Why?
| | Survival Rate | 7 | 2023 | 2087 | 0.410 |
Why?
| | DNA, Viral | 1 | 2015 | 355 | 0.390 |
Why?
| | Stroke | 2 | 2024 | 1270 | 0.390 |
Why?
| | Humans | 52 | 2025 | 145140 | 0.370 |
Why?
| | Liver Cirrhosis | 1 | 2013 | 287 | 0.340 |
Why?
| | Cardiac Resynchronization Therapy | 1 | 2012 | 63 | 0.340 |
Why?
| | Myocytes, Cardiac | 1 | 2016 | 544 | 0.340 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2012 | 229 | 0.320 |
Why?
| | Pulmonary Valve Insufficiency | 1 | 2011 | 48 | 0.320 |
Why?
| | Adrenergic beta-Antagonists | 1 | 2012 | 252 | 0.320 |
Why?
| | Autoimmunity | 1 | 2016 | 932 | 0.300 |
Why?
| | Heart Valve Prosthesis | 1 | 2011 | 129 | 0.300 |
Why?
| | Pulmonary Valve | 1 | 2011 | 101 | 0.300 |
Why?
| | Male | 31 | 2025 | 72664 | 0.300 |
Why?
| | Treatment Outcome | 13 | 2025 | 11741 | 0.300 |
Why?
| | Tachycardia, Ectopic Atrial | 1 | 2009 | 4 | 0.300 |
Why?
| | Young Adult | 12 | 2025 | 14176 | 0.290 |
Why?
| | Heart Valve Prosthesis Implantation | 1 | 2011 | 198 | 0.280 |
Why?
| | Stroke Volume | 1 | 2012 | 653 | 0.280 |
Why?
| | Surgeons | 2 | 2023 | 340 | 0.280 |
Why?
| | Female | 31 | 2025 | 78636 | 0.280 |
Why?
| | Autoantibodies | 1 | 2016 | 1508 | 0.270 |
Why?
| | Biopsy | 4 | 2021 | 1079 | 0.260 |
Why?
| | Cardiac Catheterization | 1 | 2011 | 558 | 0.260 |
Why?
| | Ambulatory Care | 1 | 2012 | 608 | 0.250 |
Why?
| | Time Factors | 8 | 2025 | 7107 | 0.250 |
Why?
| | Enterovirus Infections | 1 | 2009 | 173 | 0.240 |
Why?
| | Immunotherapy | 1 | 2011 | 665 | 0.240 |
Why?
| | Population Surveillance | 2 | 2021 | 484 | 0.220 |
Why?
| | Cardiac Surgical Procedures | 1 | 2011 | 608 | 0.220 |
Why?
| | Liver | 1 | 2013 | 1893 | 0.220 |
Why?
| | Waiting Lists | 4 | 2025 | 264 | 0.200 |
Why?
| | Glomerular Filtration Rate | 2 | 2024 | 765 | 0.200 |
Why?
| | American Heart Association | 2 | 2023 | 357 | 0.190 |
Why?
| | Calcineurin Inhibitors | 1 | 2022 | 69 | 0.190 |
Why?
| | Muscular Dystrophies | 1 | 2022 | 28 | 0.180 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2023 | 106 | 0.180 |
Why?
| | Heart | 2 | 2016 | 626 | 0.180 |
Why?
| | Cardiovascular System | 1 | 2023 | 138 | 0.170 |
Why?
| | Severity of Illness Index | 5 | 2019 | 2928 | 0.170 |
Why?
| | Device Approval | 1 | 2021 | 19 | 0.170 |
Why?
| | Cardiomyopathies | 2 | 2015 | 335 | 0.160 |
Why?
| | Transplant Recipients | 1 | 2022 | 180 | 0.160 |
Why?
| | Practice Patterns, Physicians' | 2 | 2021 | 1365 | 0.160 |
Why?
| | Risk Factors | 9 | 2025 | 10857 | 0.160 |
Why?
| | Nutritional Status | 1 | 2023 | 353 | 0.160 |
Why?
| | Dyslipidemias | 1 | 2022 | 184 | 0.150 |
Why?
| | Recombinant Fusion Proteins | 1 | 2022 | 666 | 0.150 |
Why?
| | Echocardiography | 3 | 2016 | 647 | 0.150 |
Why?
| | Patient Selection | 2 | 2021 | 733 | 0.150 |
Why?
| | Follow-Up Studies | 5 | 2024 | 5411 | 0.150 |
Why?
| | Consensus | 1 | 2021 | 478 | 0.140 |
Why?
| | Primary Graft Dysfunction | 1 | 2019 | 33 | 0.140 |
Why?
| | Heart Diseases | 1 | 2022 | 341 | 0.140 |
Why?
| | Ventricular Function | 2 | 2016 | 53 | 0.140 |
Why?
| | Posterior Leukoencephalopathy Syndrome | 1 | 2018 | 10 | 0.130 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2024 | 661 | 0.130 |
Why?
| | Immunosuppressive Agents | 1 | 2022 | 837 | 0.130 |
Why?
| | Kidney Failure, Chronic | 1 | 2023 | 599 | 0.130 |
Why?
| | Blood Group Incompatibility | 1 | 2017 | 19 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2023 | 862 | 0.130 |
Why?
| | Kidney Transplantation | 1 | 2023 | 710 | 0.130 |
Why?
| | Models, Statistical | 1 | 2021 | 671 | 0.120 |
Why?
| | Infant, Newborn | 5 | 2023 | 6435 | 0.120 |
Why?
| | Treatment Failure | 2 | 2021 | 360 | 0.120 |
Why?
| | United States | 7 | 2025 | 16065 | 0.120 |
Why?
| | Adult | 9 | 2025 | 40665 | 0.110 |
Why?
| | Kaplan-Meier Estimate | 2 | 2019 | 968 | 0.110 |
Why?
| | Antibodies, Monoclonal | 1 | 2022 | 1505 | 0.110 |
Why?
| | Cardiotonic Agents | 1 | 2014 | 94 | 0.100 |
Why?
| | Assisted Circulation | 1 | 2013 | 26 | 0.100 |
Why?
| | Databases, Factual | 1 | 2019 | 1488 | 0.100 |
Why?
| | Biomarkers | 3 | 2021 | 4282 | 0.100 |
Why?
| | Seizures | 1 | 2018 | 482 | 0.100 |
Why?
| | Liver Function Tests | 1 | 2013 | 105 | 0.100 |
Why?
| | Phenotype | 1 | 2021 | 3138 | 0.100 |
Why?
| | Echocardiography, Doppler | 1 | 2013 | 114 | 0.090 |
Why?
| | Prospective Studies | 3 | 2021 | 8035 | 0.090 |
Why?
| | Myocardium | 1 | 2018 | 931 | 0.090 |
Why?
| | Polymerase Chain Reaction | 1 | 2015 | 1039 | 0.090 |
Why?
| | Acute Disease | 2 | 2014 | 1035 | 0.090 |
Why?
| | Cohort Studies | 1 | 2022 | 5988 | 0.090 |
Why?
| | Age Factors | 4 | 2021 | 3338 | 0.080 |
Why?
| | Outpatients | 1 | 2014 | 447 | 0.080 |
Why?
| | Case-Control Studies | 2 | 2015 | 3616 | 0.080 |
Why?
| | Incidence | 3 | 2024 | 2915 | 0.080 |
Why?
| | Prosthesis Design | 1 | 2011 | 354 | 0.070 |
Why?
| | Neoplasms | 1 | 2023 | 2900 | 0.070 |
Why?
| | Quality of Life | 2 | 2022 | 3194 | 0.070 |
Why?
| | Heart Ventricles | 1 | 2012 | 754 | 0.060 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2024 | 387 | 0.060 |
Why?
| | Logistic Models | 2 | 2024 | 2133 | 0.060 |
Why?
| | Electrocardiography | 1 | 2009 | 664 | 0.060 |
Why?
| | Diagnosis, Differential | 1 | 2009 | 1506 | 0.050 |
Why?
| | Cardiotoxicity | 1 | 2023 | 35 | 0.050 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2767 | 0.050 |
Why?
| | Nutritional Support | 1 | 2023 | 39 | 0.050 |
Why?
| | Propensity Score | 1 | 2025 | 374 | 0.050 |
Why?
| | Fasting | 1 | 2023 | 276 | 0.040 |
Why?
| | Protein-Losing Enteropathies | 1 | 2021 | 10 | 0.040 |
Why?
| | Allografts | 1 | 2022 | 151 | 0.040 |
Why?
| | Perioperative Care | 1 | 2023 | 231 | 0.040 |
Why?
| | Gastrointestinal Tract | 1 | 2023 | 204 | 0.040 |
Why?
| | Medical Oncology | 1 | 2023 | 338 | 0.040 |
Why?
| | North America | 1 | 2021 | 301 | 0.040 |
Why?
| | Prognosis | 2 | 2019 | 4310 | 0.030 |
Why?
| | Pulsatile Flow | 1 | 2017 | 61 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2949 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1115 | 0.030 |
Why?
| | Health Care Surveys | 1 | 2018 | 535 | 0.030 |
Why?
| | Kidney | 1 | 2023 | 1494 | 0.030 |
Why?
| | Blood Circulation | 1 | 2015 | 44 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2019 | 1546 | 0.030 |
Why?
| | Injections, Intravenous | 1 | 2014 | 197 | 0.030 |
Why?
| | Risk Assessment | 1 | 2024 | 3740 | 0.030 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1325 | 0.030 |
Why?
| | Chagas Cardiomyopathy | 1 | 2014 | 27 | 0.020 |
Why?
| | Shock, Cardiogenic | 1 | 2014 | 65 | 0.020 |
Why?
| | Endocarditis, Bacterial | 1 | 2014 | 46 | 0.020 |
Why?
| | Natriuretic Peptide, Brain | 1 | 2013 | 109 | 0.020 |
Why?
| | Animals | 2 | 2014 | 37952 | 0.020 |
Why?
| | Quality Improvement | 1 | 2021 | 1293 | 0.020 |
Why?
| | Virus Diseases | 1 | 2014 | 216 | 0.020 |
Why?
| | Practice Guidelines as Topic | 1 | 2019 | 1579 | 0.020 |
Why?
| | Heart Rate | 1 | 2013 | 855 | 0.020 |
Why?
| | Prevalence | 1 | 2016 | 2855 | 0.020 |
Why?
| | Obesity | 1 | 2022 | 3097 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2013 | 2115 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2014 | 4552 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2015 | 6055 | 0.010 |
Why?
| | Middle Aged | 1 | 2021 | 36126 | 0.010 |
Why?
|
|
Simpson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|